Yasar Culha

Afyonkarahisar, Turkey

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinoma.

Prognostic factors in avelumab maintenance therapy for metastatic urothelial carcinoma.

Journal: Immunotherapy

Published: September 02, 2026

Palliative Care Awareness Among Caregivers of Cancer Patients in Turkey: A Cross-Sectional Study.

Palliative Care Awareness Among Caregivers of Cancer Patients in Turkey: A Cross-Sectional Study.

Journal: Current oncology (Toronto, Ont.)

Published: June 16, 2026

Aprepitant and Fosaprepitant for Preventing Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy-A Real-World Study.

Aprepitant and Fosaprepitant for Preventing Nausea and Vomiting in Patients Receiving Highly Emetogenic Chemotherapy-A Real-World Study.

Journal: Current oncology (Toronto, Ont.)

Published: May 13, 2026

The Effect of HER3 Expression on Prognosis in EGFR-Mutant Non-Small Cell Lung Cancer: A Retrospective Real-World Study.

The Effect of HER3 Expression on Prognosis in EGFR-Mutant Non-Small Cell Lung Cancer: A Retrospective Real-World Study.

Journal: Medicina (Kaunas, Lithuania)

Published: February 22, 2026

Prognostic Value of the Lung Immune Prognostic Index (LIPI) in Patients with Renal Cell Carcinoma: A Retrospective Cohort Study.

Prognostic Value of the Lung Immune Prognostic Index (LIPI) in Patients with Renal Cell Carcinoma: A Retrospective Cohort Study.

Journal: Journal of clinical medicine

Published: December 11, 2025

Prognostic nutritional index, but not NLR or PLR, is linked to survival in multiple myeloma.

Prognostic nutritional index, but not NLR or PLR, is linked to survival in multiple myeloma.

Journal: Frontiers in oncology

Published: November 13, 2025

Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program.

Avelumab maintenance in patients with metastatic urothelial carcinoma in a real-life expanded-access program.

Journal: Future oncology (London, England)

Published: October 17, 2025

Is the risk of brain metastasis and prognosis different in HER2-low breast cancer?

Is the risk of brain metastasis and prognosis different in HER2-low breast cancer?

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: August 16, 2025

Clinical and prognostic effects of microvascular density and FOXP3 positive T cells in breast cancer.

Clinical and prognostic effects of microvascular density and FOXP3 positive T cells in breast cancer.

Journal: Scientific reports

Published: August 20, 2024

The Utility of the Cachexia Index and the Modified Glasgow Score in Young Patients With Breast Cancer.

The Utility of the Cachexia Index and the Modified Glasgow Score in Young Patients With Breast Cancer.

Journal: Cureus

Published: April 29, 2024

Comparison of clinicopathological and prognostic features of breast cancer patients younger than 40 years and older than 65 years.

Comparison of clinicopathological and prognostic features of breast cancer patients younger than 40 years and older than 65 years.

Journal: Discover oncology

Published: December 07, 2023

Showing 1-11 of 11

Last Updated: 09/26/2026